Invading basement membrane matrix is sufficient for MDA-MB-231 breast cancer cells to develop a stable in vivo metastatic phenotype

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Abdelkarim, Mohamed ^a,b   Vintonenko, Nadejda ^a,b   Starzec, Anna ^a   Robles, Aniela ^a,c   Aubert, Julie ^d   Martin, Marie Laure ^d,e   Mourah, Samia ^c   Podgorniak, Marie Pierre ^c   Rodrigues Ferreira, Sylvie ^c,f   Nahmias, Clara ^c,f   Couraud, Pierre Olivier ^c,f   Doliger, Christelle ^g   Sainte Catherine, Odile ^a   Peyri, Nicole ^a,c   Chen, Lei ^b   Mariau, Jérémie ^b   Etienne, Monique ^a   Perret, Gerard Yves ^a   Crepin, Michel ^b   Poyet, Jean Luc ^c   Khatib, Abdel Majid ^c,h   Di Benedetto, Mélanie ^a,c   more..

^a UNIVERSITÉ PARIS 13   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d AgroParisTech   (France)

^e INSTITUTE OF PLANT SCIENCES PARIS SACLAY IPS2   (France)

^f INSTITUT COCHIN   (France)

^g SAINT LOUIS HOSPITAL   (France)

^h UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; ANGIOGENIC PROTEIN; APOPTOSIS REGULATORY PROTEIN; COLLAGEN; LAMININ; MATRIGEL; PROTEOGLYCAN; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; CANCER CELL; CANCER SURVIVAL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENOTYPE; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; TRANSCRIPTOMICS; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; ANIMAL; BREAST TUMOR; CANCER INVASION; DNA MICROARRAY; DRUG COMBINATION; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

MUS; MUS MUSCULUS;

ANGIOGENIC PROTEINS; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BASEMENT MEMBRANE; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; COLLAGEN; DRUG COMBINATIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 80051704396     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023334     Document Type: Article

References (47)

1. Perret GY, Crepin M, (2008) New pharmacological strategies against metastatic spread. Fundamental & Clinical Pharmacology 5: 465-492.
2. Shekhar MP, Pauley R, Heppner G, (2003) Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res 5: 130-135.
3. Haslam SZ, Woodward TL, (2001) Reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland. Breast Cancer Res 3: 365-372.
4. Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, et al. (1992) Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors. J Androl 13: 465-475.
5. Erler JT, Weaver VM, (2009) Three-dimensional context regulation of metastasis. Clinical & Experimental Metastasis 26: 35-49.
6. Shekhar MP, Werdell J, Santner SJ, Pauley RJ, Tait L, (2001) Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res 15: 1320-1326.
7. Hynes RO, (2009) The extracellular matrix: not just pretty fibrils. Science 27: 1216-1219.
8. Engbring JA, Kleinman HK, (2003) The basement membrane matrix in malignancy. J Pathol 200: 465-470.
9. Yang L, (2010) TGF beta and cancer metastasis: an inflammation link. Cancer Metastasis Rev 29: 263-271.
10. Brekhman V, Neufeld G, (2009) A novel asymmetric 3D in-vitro assay for the study of tumor cell invasion. BMC Cancer 30: 415.
11. Pupa SM, Ménard S, Forti S, Tagliabue E, (2002) New insights into the role of extracellular matrix during tumor onset and progression. J Cell Physiol 192: 259-267.
12. Kleinman HK, Koblinski J, Lee S, Engbring J, (2001) Role of basement membrane in tumor growth and metastasis. Surg Oncol Clin N Am 10: 329-38.
13. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, et al. (1986) Basement membrane complexes with biological activity. Biochemistry 28: 312-318.
14. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, et al. (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 15: 3239-3245.
15. Cailleau R, Young R, Olivé M, Reeves WJ Jr, (1974) Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53: 661-674.
16. Weksler BB, Subileau EA, Perrière N, Charneau P, Holloway K, et al. (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 13: 1872-1874.
17. Poller B, Gutmann H, Krähenbühl S, Weksler B, Romero I, et al. (2008) The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies. J Neurochem 107: 1358-1368.
18. Di Benedetto M, Starzec A, Vassy R, Crépin M, Kraemer M, (2003) Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative. Br J Cancer 88: 1987-1994.
19. Di Benedetto M, Bièche I, Deshayes F, Vacher S, Nouet S, et al. (2006) Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene 380: 127-136.
20. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2: 249-264.
21. Delmar P, Robin S, VarMixt DaudinJ.-J, (2005) Efficient variance modelling for the differential analysis of replicated gene expression data. Bioinformatics 4: 502-508.
22. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B57:1: 289-300.
23. Storey JD, Tibshirani R, (2003) Statistical significance for genome-wide experiments. Proc Nat Acad Sci USA 100: 9440-9445.
24. Hamma-Kourbali Y, Di Benedetto M, Ledoux D, Oudar O, Leroux Y, et al. (2003) A novel non-containing-nitrogen bisphosphonate inhibits both in vitro and in vivo angiogenesis. Biochem Biophys Res Comm 310: 816-882.
25. Abdelkarim M, Guenin E, Sainte-Catherine O, Vintonenko N, Peyri N, et al. (2009) New symmetrically esterified m-bromobenzyl non-aminobisphosphonates inhibited breast cancer growth and metastases. PLoS One 4: e4685.
26. Orr FW, Wang HH, Lafrenie RM, Scherbarth S, Nance DM, (2000) Interactions between cancer cells and the endothelium in metastasis. J Pathol 190: 310-329.
27. Wang T, Lv JH, Zhang XF, Li CJ, Han X, Sun YJ, (2010) Tissue inhibitor of metalloproteinase-1 protects MCF-7 breast cancer cells from paclitaxel-induced apoptosis by decreasing the stability of cyclin B1. Int J Cancer 15: 362-70.
28. Lei X, Yang J, Nichols RW, Sun LZ, (2007) Abrogation of TGFbeta signaling induces apoptosis through the modulation of MAP kinase pathways in breast cancer cells. Exp Cell Res 2007 313: 1687-1695.
29. De Angelis PM, Fjell B, Kravik KL, Haug T, Tunheim SH, et al. (2004) Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil. Int J Oncol 24: 1279-1288.
30. Sweeney KJ, Sarcevic B, Sutherland RL, Musgrove EA, (1997) Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells. Oncogene 14: 1329-1340.
31. Kranz, Mattfeldt T, Waltenberger J, (1999) Molecular mediators of tumor angiogenesis: enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer. Int J Cancer 84: 293-298.
32. Hicklin DJ, Ellis LM, (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23: 1011-27.
33. Weigand M, Hantel P, Kreienberg R, Waltenberger J, (2005) Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. Angiogenesis 3: 197-204.
34. Aesoy R, Sanchez BC, Norum JH, Lewensohn R, Viktorsson K, Linderholm B, (2008) An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells. Mol Cancer Res 10: 1630-1638.
35. Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, et al. (2001) Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 15: 5736-5740.
36. Jenkins DE, Hornig YS, Oei Y, Dusich J, Purchio T, (2005) Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice. Breast Cancer Res 7: 444-454.
37. Weiss L, Grundmann E, Torhorst J, Moberg I, Eder M, Fenoglio-Preiser CM, et al. (1986) Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150: 195-203.
38. Aokage K, Ishii G, Ohtaki Y, Yamaguchi Y, Hishida T, et al. (2010) Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation. Int J Cancer in press.
39. Tsuji T, Ibaragi S, Hu GF, (2009) Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 69: 7135-7139.
40. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
41. Weis S, Cui J, Barnes L, Cheresh D, (2004) Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 167: 223-229.
42. Fan Y, Dutta J, Gupta N, Fan G, Gélinas C, (2008) Regulation of programmed cell death by NF-kappaB and its role in tumorigenesis and therapy. Adv Exp Med Biol 615: 223-250.
43. Berezovskaya O, Schimmer AD, Glinskii AB, Pinilla C, Hoffman RM, et al. (2005) Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res 15: 2378-2386.
44. Yang S, Zhou Q, Yang X, (2007) Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells. Biochim Biophys Acta 1773: 903-911.
45. Rajaraman R, Guernsey DL, Rajaraman MM, Rajaraman SR, (2006) Stem cells, senescence, neosis and self-renewal in cancer. Cancer Cell Int 6: 25.
46. Mehlen P, Puisieux A, (2006) Metastasis: a question of life or death. Nat Rev Cancer 6: 449-458.
47. Rajaraman R, Guernsey DL, Rajaraman MM, Rajaraman SR, (2006) Stem cells, senescence, neosis and self-renewal in cancer. Cancer Cell Int 6: 25.